Sleep-AID: a cross-sectional analysis of subjective sleep quality, psychosocial measures and real-world glycemic outcomes in people with diabetes using automated insulin delivery systems.

Drew Cooper, Tebbe Ubben, Christine Knoll, Christine Blume, Wolf-Julian Neumann, Katarina Braune

Abstract read

In one paragraph

Article in Sleep advances : a journal of the Sleep Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Drew CooperCharité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Invalidenstraße 90, 10115 Berlin, Germany.ORCID https://orcid.org/0000-0003-3847-8416

Tebbe UbbenCharité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Invalidenstraße 90, 10115 Berlin, Germany.

Christine KnollCharité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Invalidenstraße 90, 10115 Berlin, Germany.

Christine BlumeCentre for Chronobiology, Psychiatric Hospital of the University of Basel, Basel, Switzerland.

Wolf-Julian NeumannCharité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neurology with Experimental Neurology, Movement Disorders and Neuromodulation Unit, Charitéplatz 1, 10117 Berlin, Germany.ORCID https://orcid.org/0000-0002-6758-9708

Katarina BrauneCharité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Medical Informatics, Invalidenstraße 90, 10115 Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Study Objectives: Sleep disturbances are common in people with diabetes, yet their relationship to automated insulin delivery (AID) use has not been well described in large, real-world cohorts. We assessed subjective sleep quality, fear of hypoglycemia, and their associations with glycemic outcomes among adults with diabetes using open-source and commercial AID compared with non-users. Materials and Methods: We conducted a cross-sectional analysis of 529 adults from the OPEN Project (2020-2023). Participants completed the Pittsburgh Sleep Quality Index (PSQI) and Hypoglycemia Fear Survey-II (HFS-II) short form. All participants self-reported glycated hemoglobin (HbA1c) levels; a subsample of 60 AID users contributed ≥25 days of continuous glucose monitoring (CGM) data. Free-text responses to PSQI item 5j were thematically coded. Results: AID users reported better sleep (median 5 [IQR 3-7] vs. 7 [IQR 5-9], Conclusions: Adults using AID systems reported better sleep quality and lower fear of hypoglycemia than those managing diabetes without automation, yet a large proportion of all participants continued to experience poor sleep. Diabetes-related nocturnal disruptions remained common among non-users, suggesting that AID may alleviate-but not eliminate-the nighttime diabetes burden.

Indexed as

automated insulin delivery systemconsumer sleep technologydiabetesGlycemic variabilityHypoglycemia fearperson-reported outcome measuresquality of lifesleep and stresssleepinesssleep quality

Identifiers

PMID42529753

DOI10.1093/sleepadvances/zpag066

PMCPMC13419071

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.